Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HealthCare Global Enterprises has a current ratio of . It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If HealthCare Global Enterprises has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.
The historical rank and industry rank for HealthCare Global Enterprises's Current Ratio or its related term are showing as below:
NSE:HCG'
s Current Ratio Range Over the Past 10 Years
Min: 0.5 Med: 0.86 Max: 1.12
Current: 1.12
During the past 13 years, HealthCare Global Enterprises's highest Current Ratio was 1.12. The lowest was 0.50. And the median was 0.86.
NSE:HCG's Current Ratio is ranked worse than 65.31% of 686
companies
in the Healthcare Providers & Services industry
Industry Median: 1.435
vs NSE:HCG: 1.12
HealthCare Global Enterprises (NSE:HCG) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
HealthCare Global Enterprises Current Ratio Related Terms
HealthCare Global Enterprises Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:HCG vs HCA, THC, EHC: Current Ratio Comparison
For the Medical Care Facilities subindustry, HealthCare Global Enterprises's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HealthCare Global Enterprises Current Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, HealthCare Global Enterprises's Current Ratio distribution charts can be found below:
* The bar in red indicates where HealthCare Global Enterprises's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Is HealthCare Global Enterprises (NSE:HCG) Overvalued in 2026?
Based on GuruFocus' analysis, HealthCare Global Enterprises stock appears to be overvalued.
The current stock price of ₹701.35 is trading 15.6% above its estimated GF Value™ of ₹606.84.
GuruFocus considers HealthCare Global Enterprises to be Modestly Overvalued.
Key valuation signals for NSE:HCG:
Current Ratio:
GF Value™: ₹606.84 vs. price of ₹701.35 (15.6% above fair value)
No single metric tells the full story. See the NSE:HCG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
HealthCare Global Enterprises Ltd operates in oncology, providing comprehensive cancer diagnosis and treatment services including medical oncology, radiation therapy, and surgical oncology. It also offers fertility treatment services under the Milann brand, along with multi-specialty hospital care in key medical disciplines. The company's operations span many metropolitan and non-metro cities across India and extend internationally with cancer care centers in Africa. HCG generates revenue through patient services in oncology, fertility treatments, diagnostics, and multi-specialty hospital care, leveraging technology and a networked business model to deliver patient-centric healthcare.
81GF Score
Get the complete analysis for NSE:HCG
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:HCG has been successfully added to your 
